The International AIDS Conference starts up in less than a week in Vienna, Austria. ScienceSpeaks is gathering thoughts from leaders in the field HIV/AIDS treatment, research and advocacy in the question and answer series “Looking toward Vienna.” Daniel R. Kuritzkes, MD, is a Professor of Medicine at Harvard Medical School. He is also the Head […]
A piece in last week’s Science Magazine argues for universal access to prevention and treatment for HIV/AIDS. Looking back to the 2006 pledge made by all UN member states to make universal access a reality by 2010, the article states that the global community has failed to deliver and calls for more resources and attention […]
The International AIDS Society (IAS) announced Monday that the HIV Medicine Association (HIVMA) of the Infectious Diseases Society of America (IDSA), with its Center for Global Health Policy, will be one of two local scientific partners for the 2012 International AIDS Conference — to be held in Washington, DC in July 2012. HIVMA represents more […]
HIV
The goals of controlling HIV sound like a straight forward series of three consecutive steps, one following another, when discussed in global and domestic epidemic-ending plans. […]
Tuberculosis
The announcement Wednesday of U.S. Food and Drug Administration approval of pretomanid, a new tuberculosis drug that has been part of a ground-breaking treatment regimen against […]
Research & Development
A randomized, multi-country clinical trial testing a regimen for treating drug-resistant tuberculosis in less than a year against the up to two-year regimen recommended by the […]
Policy
With a report showing that 2018 yielded the highest case numbers seen so far of a paralyzing condition largely among children who had been sick with […]